The medtech sector drew about $2 billion in investments from seven deals during the second quarter of this year, down from more than $25 billion raised from 16 deals during the same period last year, according to a PricewaterhouseCoopers report. Analysts, however, expressed optimism that readily available financing and other factors will lead to increased activity in the sector throughout the remainder of the year.

Related Summaries